Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Elkin V. Lemos"'
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 27, Iss 3, Pp 102759- (2023)
Introduction: The incidence of antimicrobial resistance is increasing in many parts of the world. The focus of this report is to examine changes in antimicrobial resistance epidemiology among clinical isolates of Enterobacterales and Pseudomonas aeru
Externí odkaz:
https://doaj.org/article/cb534f9cffac4c5d84417658d2f1ea3c
Autor:
Elkin V. Lemos-Luengas, MD, PhD, Sixta Rentería-Valoyes, MD, Paola Cárdenas-Isaza, MD, MSc, Jorge A. Ramos-Castaneda, PhD
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 29, Iss , Pp 141-146 (2022)
ABSTRACT: Objectives: Ceftazidime/avibactam (CAZ/AVI) has shown in vitro activity against multidrug-resistant (MDR) Gram-negative bacteria, especially Enterobacterales and carbapenem-resistant Pseudomonas aeruginosa. However, in vitro activity of CAZ
Externí odkaz:
https://doaj.org/article/c0bd0f9e5a7541969b649c95a01bdc88
Autor:
Elkin V. Lemos-Luengas, Sixta Rentería-Valoyes, Paola Cárdenas-Isaza, Jorge A. Ramos-Castaneda
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 26, Iss 3, Pp 102369- (2022)
Ceftazidime/avibactam (CAZ/AVI) has excellent in vitro activity against enterobacterales and Pseudomonas aeruginosa. The study aimed to analyze the in vitro antimicrobial activity of CAZ/AVI and other antibiotics against isolates of enterobacterales
Externí odkaz:
https://doaj.org/article/d69d9b5ddc0549fdb0c07b01997f9f44
Publikováno v:
Biomédica: revista del Instituto Nacional de Salud, Vol 40, Iss 1, Pp 195-207 (2020)
En Colombia, especialmente en las unidades de cuidados intensivos, la candidemia es una causa frecuente de infección del torrente sanguíneo y representa el 88 % de las infecciones fúngicas en pacientes hospitalizados, con una mortalidad entre 36 y
Externí odkaz:
https://doaj.org/article/ba370948cca749678af69936f0332071
Autor:
Jorge A. Ramos-Castaneda, Javier Osorio-Manrique, Alberto Ruano-Ravina, Jackeline Barreto-Mora, Elkin V. Lemos-Luengas, Angela M. Segura-Cardona
Publikováno v:
Urología Colombiana, Vol 30, Iss 03, Pp e157-e164 (2021)
Objectives To identify the effect of duration of surgical antibiotic prophylaxis (SAP) and other variables on infectious postsurgical complications in patients with asymptomatic bacteriuria (ASB) undergoing urological surgery. Methods We conducted an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed042992de3ababdc72bce9044625a56
https://doi.org/10.1055/s-0041-1730320
https://doi.org/10.1055/s-0041-1730320
Publikováno v:
Biomédica: revista del Instituto Nacional de Salud, Vol 40, Iss 1, Pp 195-207 (2020)
Biomédica, Volume: 40, Issue: 1, Pages: 195-207, Published: MAR 2020
Biomédica : Revista del Instituto Nacional de Salud
Biomédica, Volume: 40, Issue: 1, Pages: 195-207, Published: MAR 2020
Biomédica : Revista del Instituto Nacional de Salud
Resumen En Colombia, especialmente en las unidades de cuidados intensivos, la candidemia es una causa frecuente de infección del torrente sanguíneo y representa el 88 % de las infecciones fúngicas en pacientes hospitalizados, con una mortalidad en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa676d79386921629a97aa43604fd7fe
https://revistabiomedica.org/index.php/biomedica/article/view/4400
https://revistabiomedica.org/index.php/biomedica/article/view/4400
Autor:
Rodrigo Toro-Bermúdez, Jorge A. Ramos-Castaneda, Alberto Ruano-Ravina, L. Silvia Munoz-Price, David Ruiz-Londoño, Elkin V. Lemos-Luengas, Angela M. Segura-Cardona
Publikováno v:
American Journal of Infection Control. 47:1474-1478
Background Treatment of asymptomatic bacteriuria (ASB) is recommended in pregnant women and prior to urologic procedures with anticipated mucosal disruption. However, there is still insufficient evidence of the usefulness of treating ASB prior to uro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89c2f027ec083e11113c400947daf765
https://doi.org/10.1016/j.ajic.2019.06.024
https://doi.org/10.1016/j.ajic.2019.06.024
Autor:
Jorge A. Ramos-Castaneda, Diego F. Salinas, Angela M. Segura-Cardona, Elkin V. Lemos-Luengas, Alberto Ruano-Ravina, Javier Osorio-Manrique
Publikováno v:
American Journal of Infection Control. 47:1479-1483
Background Although the factors associated to bacterial resistance in patients with asymptomatic bacteriuria (ASB) have been studied in pregnant, fertile age women, patients with spinal cord injury, and those with urogynecological disorders, nothing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1d4793f240dea811838924dc8514da
https://doi.org/10.1016/j.ajic.2019.06.005
https://doi.org/10.1016/j.ajic.2019.06.005
Autor:
Javier C. Saldaña-Campos, Jaime E. Paillier-Gonzalez, Raquel Barbosa-Lorenzo, Diego F. Salinas, Elkin V. Lemos-Luengas, Alberto Ruano-Ravina, Jorge A. Ramos-Castaneda
Publikováno v:
Journal of Infection. 76:438-448
Introduction KPC carbapenemase-producing Klebsiella pneumoniae (KPC-KP) has become a major public health challenge. Accordingly, this study sought to use a systematic review of the scientific literature to ascertain the mortality of KPC-KP infection,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b5865580c9f20ba52782ea58ea0f79f
https://doi.org/10.1016/j.jinf.2018.02.007
https://doi.org/10.1016/j.jinf.2018.02.007
Autor:
Paurus Irani, Alvaro Quintana, Greg Stone, Maria Lavínea Novis de Figueiredo Valente, Elkin V Lemos, Monique Baudrit, Daniel F. Sahm, Krystyna M. Kazmierczak
Publikováno v:
Open Forum Infectious Diseases
Background Ceftazidime-avibactam (CAZ-AVI) is a β-lactam/non-β-lactam β-lactamase inhibitor combination with in vitro activity against Enterobacterales (Ent) and Pseudomonas aeruginosa (Psa) carrying Class A, C and some Class D β-lactamases. We e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2624fc997e911097aa567690bc9cce7d
https://doi.org/10.1093/ofid/ofaa439.1760
https://doi.org/10.1093/ofid/ofaa439.1760